Melinda G. Hollingshead

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

J I Johnson, Shannon Decker, Daniel Zaharevitz et al. · British Journal of Cancer · 2001 · 858 citations · Full text

Medicine, Oncology, Pharmacology +14

The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity

Susan L. Holbeck, Richard F. Camalier, James A. Crowell et al. · Cancer Research · 2017 · 392 citations · Full text

Medicine, Oncology, Pharmacology +12

Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents

Brian K. Adams, Eva Ferstl, Matthew C. Davis et al. · Bioorganic & Medicinal Chemistry · 2004 · 390 citations

Medicine, Medicinal Chemistry, Oncology +15

Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol

Lloyd T. Lam, Oxana K. Pickeral, A Peng et al. · Genome biology · 2001 · 373 citations · Full text

Life Sciences, Oncology, Pharmacology +15

In vivo cultivation of tumor cells in hollow fibers

Melinda G. Hollingshead, Michael C. Alley, Richard F. Camalier et al. · Life Sciences · 1995 · 344 citations

Engineering, Bioengineering, Biomedical Engineering +16